Envestnet Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-10,500
Closed -$9.56K 3975
2023
Q1
$9.56K Hold
10,500
﹤0.01% 3950
2022
Q4
$8.93K Hold
10,500
﹤0.01% 3940
2022
Q3
$9K Hold
10,500
﹤0.01% 3883
2022
Q2
$10K Hold
10,500
﹤0.01% 3898
2022
Q1
$17K Hold
10,500
﹤0.01% 3906
2021
Q4
$25K Hold
10,500
﹤0.01% 3842
2021
Q3
$51K Hold
10,500
﹤0.01% 3635
2021
Q2
$28K Hold
10,500
﹤0.01% 3618
2021
Q1
$32K Buy
+10,500
New +$32K ﹤0.01% 3467